Co-Authors
This is a "connection" page, showing publications co-authored by Eric Bartee and Bulent Aksoy.
Connection Strength
0.403
-
The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors. J Immunother. 2023 Jan 01; 46(1):1-4.
Score: 0.219
-
Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication. J Immunother Cancer. 2020 06; 8(1).
Score: 0.185